Nebula Research & Development LLC Elanco Animal Health Inc Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
A detailed history of Nebula Research & Development LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 145,645 shares of ELAN stock, worth $1.69 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
145,645Holding current value
$1.69 Million% of portfolio
0.26%Shares
3 transactions
Others Institutions Holding ELAN
# of Institutions
437Shares Held
473MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$969 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$611 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.9MShares$569 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$271 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$248 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.51B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...